Abstract
The application of immunotherapy in the treatment of hematological malignancies is relatively new. Donor lymphocyte infusion (DLI) is a form of adaptive cellular therapy where the transfer of cells from immunocompetent donor to patient with cancer who relapsed after bone marrow transplantation results in destruction of the malignant cells. Hereby, we review the concepts, mechanisms, and results of the application of DLI in treatment of some hematological malignancies.
- Copyright: © Saudi Medical Journal
This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Jump to section
Related Articles
Cited By...
- No citing articles found.